EUSA Pharma (Denmark) ApS: Financial statements 2019
CVR: 39055988
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
EUSA Pharma (Denmark) ApS (CVR 39055988) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,058,784 and a net result of DKK 228,408. Equity in the 2019 report amounted to DKK 215,458. The solvency ratio was 24.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,058,784
- Profit/Loss
- DKK 228,408
- Equity
- DKK 215,458
- Total Assets
- DKK 889,364
- Employees
- 3
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
EUSA Pharma (Denmark) ApS has published its interim report for the period November 2, 2017 – December 31, 2018.
About EUSA Pharma (Denmark) ApS
EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 19 December 2024. The company was registered under the industry Reklamebureauer. According to the 2023 annual report, the company had an average of 1 employee. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity in the 2023 report amounted to DKK 1,644,740.